Abstract
1038 - Overall survival with abiraterone acetate plus prednisone vs. docetaxel for the treatment of metastatic hormone-sensitive prostate cancer: An updated network meta-analysis
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have